• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (33)
    • United States Department of Defense
    • Identification of Lynch syndrome among patients with colorectal cancer.
    • Cefadroxil
    • Reversible expression of CD34 by murine hematopoietic stem cells.
    • Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome.
    • See All 33 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome.

Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome. Br J Cancer. 2019 11; 121(10):869-876.

View in: PubMed

subject areas
  • Adult
  • Aged
  • Aged, 80 and over
  • Cholesterol
  • Colorectal Neoplasms
  • Colorectal Neoplasms, Hereditary Nonpolyposis
  • Diabetes Mellitus, Type 2
  • DNA Mismatch Repair
  • Epithelial Cell Adhesion Molecule
  • Female
  • Genetic Predisposition to Disease
  • Germ-Line Mutation
  • Humans
  • Male
  • Middle Aged
  • Mismatch Repair Endonuclease PMS2
  • MutL Protein Homolog 1
  • MutS Homolog 2 Protein
  • Proportional Hazards Models
  • Risk Factors
  • Triglycerides

authors with profiles
  • Robert W. Haile